A putative role for telocytes in placental barrier impairment during preeclampsia

Medical Hypotheses

Volumn 84, Issue 1, 2015, Pages 72-77

  Bosco, C ^a   Diaz E ^a   Gutierrez R ^a   Gonzalez J ^a   Parra Cordero, M ^b   Rodrigo, R ^a   Barja, P ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BLOOD PLACENTA BARRIER; CELL TYPE; CHORION VILLUS; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; HUMAN CELL; HYPOXIA; INTERSTITIAL CELL OF CAJAL; ISCHEMIA; MATERNAL BLOOD; MESODERM; MYOFIBROBLAST; NECROSIS; OXIDATIVE STRESS; PLACENTA; PREECLAMPSIA; PREGNANT WOMAN; STROMA CELL; TELOCYTE; TRANSMISSION ELECTRON MICROSCOPY; TROPHOBLAST; VASCULAR SMOOTH MUSCLE; VASCULARIZATION; BIOLOGICAL MODEL; CYTOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY;

FEMALE; HUMANS; MESODERM; MODELS, BIOLOGICAL; OXIDATIVE STRESS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; STROMAL CELLS;

EID: 84918793724     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2014.11.019     Document Type: Article

References (74)

1. Roberts J.M., Cooper D.W. Pathogenesis and genetics of preeclampsia. Lancet 2001, 357:53-56.
2. Redman C.W.C. Current topic: pre-eclampsia and the placenta. Placenta 1991, 12:301-308.
3. Meiss P.J., Goldenberg R.L., Mercer B.M., Iams J.D., Moawad A.H., Miodovnik M. The preterm prediction study: risk factor for indicated preterm births. Am J Obstet Gynecol 1998, 178:562-567.
4. Parra-Cordero M., Rodrigo R., Barja P., et al. Prediction of early and late pre-eclampsia from maternal characteristics, uterine artery Doppler and markers of vasculogenesis during first trimester of pregnancy. Ultrasound Obstet Gynecol 2013, 41:538-544.
5. Zhou Y., Damsky C.H., Chiu K., Roberts J.M., Fisher S.J. Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblast. J Clin Invest 1993, 91:950-960.
6. Di Federico E., Genbacev O., Fisher S.J. Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol 1999, 155:293-301.
7. Many A., Hubel C.A., Fisher S.J., Roberts J.M., Zhou Y. Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am J Pathol 2000, 156:321-331.
8. Khalil R.A., Granger J.P. Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol 2002, 283:R29-R45.
9. Parra M., Rodrigo R., Barja P., et al. Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction. Am J Obstet Gynecol 2005, 193:1486-1491.
10. Parra-Cordero M., Bosco C., González J., Gutiérrez R., Barja P., Rodrigo R. Immunohistochemical expression of von Willebrand factor in the preeclamptic placenta. J Mol Histol 2011, 42:459-465.
11. Bosco C., Parra M., Barja P., et al. Increased immunohistochemical expression of thrombomodulin at placental perivascular myofibroblast in severe preeclampsia (PE). Histol Histopathol 2005, 4:1045-1055.
12. Wathén K.A., Tuutti E., Stenman U.-H., et al. Maternal serum soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation. J Clin Endocrinol Metab 2006, 91:180-184.
13. Kharb S. Vitamin E and C in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2000, 93:37-39.
14. Rodrigo R., Parra M., Bosco C., et al. Pathophysiological basis for the prophylaxis of preeclampsia through early supplementation with antioxidant vitamins. Pharmacol Ther 2005, 107:177-197.
15. Bowen R.S., Moodley J., Dutton M.F., Theron A.J. Oxidative stress in pre-eclampsia. Acta Obstet Gynecol Scand 2001, 80:719-725.
16. Serdar Z., Gür E., Develioglu O., Develioğlu O., Colakoğullari M., Dirican M. Placental and decidual lipid peroxidation and antioxidant defenses in preeclampsia. Lipid peroxidation in preeclampsia. Pathophysiology 2002, 9:21-25.
17. Liochev S.I., Fridovich I. How does superoxide dismutase protect against tumor necrosis factor: a hypothesis informed by effect of superoxide on "free" iron. Free Radic Biol Med 1997, 23:668-671.
18. Myatt L., Cui X. Oxidative stress in the placenta. Histochem Cell Biol 2004, 122:369-382.
19. Davidge S.T. Oxidative stress and altered endothelial cell function in preeclampsia. Semin Reprod Endocrinol 1998, 16:65-73.
20. Walsh S.W., Vaughan J.E., Wang Y., Roberts L.J. Placental isoprostane is significantly increased in preeclampsia. FASEB J 2000, 14:1289-1296.
21. Wang Y., Walsh S.W. Antioxidant activities and mRNA expression of superoxide dismutase, catalase, and glutathione peroxidase in normal and preeclamptic placentas. J Soc Gynecol Investig 1996, 3:179-184.
22. Bae I., Fan S., Meng Q., et al. BRCA1 induces antioxidant gene expression and resistance to oxidative stress. Cancer Res 2004, 64:7893-7909.
23. Qanungo S., Mukherjea M. Ontogenic profile of some antioxidants and lipid peroxidation in human placental and fetal tissues. Mol Cell Biochem 2000, 215:11-19.
24. Jones M.L., Mark P.J., Lewis J.L., Mori T.A., Keelan J.A., Waddell B.J. Antioxidant defenses in the rat placenta in late gestation: increased labyrinthine expression of superoxide dismutases, glutathione peroxidase 3, and uncoupling protein 2. Biol Reprod 2010, 83:254-260.
25. Das B., Saha-Roy S., Saha-Roy S., Das Gupta A., Lahiri T.K., Das H.N. Assessment of placental oxidative stress in pre-eclampsia. J Obstet Gynaecol India 2012, 62:39-42.
26. Huppertz B., Kingdom J., Caniggia I., et al. Hypoxia favours necrotic versus apoptotic shedding of placental syncytiotrophoblast into the maternal circulation. Placenta 2003, 24:181-190.
27. Sharp A.N., Heazell A.E., Crocker I.P., Mor G. Placental apoptosis in health and disease. Am J Reprod Immunol 2010, 64:159-169.
28. Smith S.C., Baker P.N., Symonds E.M. Placental apoptosis in normal human pregnancy. Am J Obstet Gynecol 1997, 177:57-65.
29. Myatt L. Role of placenta in preeclampsia. Endocrine 2002, 19:103-111.
30. Huppertz B., Kadyrov M., Kingdom J.C. Apoptosis and its role in the trophoblast. Am J Obstet Gynecol 2006, 195:29-39.
31. Allaire A.D., Ballenger K.A., Wells S.R., McMahon M.J., Lessey B.A. Placental apoptosis in preeclampsia. Obstet Gynecol 2000, 96:271-276.
32. Aban M., Cinel L., Arslan M., et al. Expression of nuclear factor-kappa B and placental apoptosis in pregnancies complicated with intrauterine growth restriction and preeclampsia: an immunohistochemical study 2004, 204:195-202.
33. Heazell A.E., Crocker I.P. Live and let die - regulation of villous trophoblast apoptosis in normal and abnormal pregnancies. Placenta 2008, 29:772-783.
34. Burton G.J., Jones C.J. Syncytial knots, sprouts, apoptosis, and trophoblast deportation from the human placenta. Taiwan J Obstet Gynecol 2009, 48:28-37.
35. Tjoa M.L., Cindrova-Davies T., Spasic-Boskovic O., Bianchi D.W., Burton G.J. Trophoblastic oxidative stress and the release of cell-free feto-placental DNA. Am J Pathol 2006, 169:400-404.
36. Cobellis L., De Falco M., Torella M., et al. Modulation of Bax expression in physiological and pathological human placentas throughout pregnancy. In Vivo 2007, 21:777-784.
37. Farrugia G. Interstitial cells of Cajal in health and disease. Neurogastroenterol Motil 2008, 20:54-63.
38. Wang X.Y., Diamant N.E., Huizinga J.D. Interstitial cells of Cajal: pacemaker cells of the pancreatic duct?. Pancreas 2001, 40:137-143.
39. Popescu L.M., Faussone-Pellegrini M.S. Telocytes - a case of serendipity: the winding way from Interstitial Cells of Cajal (ICC), via Interstitial Cajal-Like Cells (ICLC) to telocytes. J Cell Mol Med 2010, 14:729-740.
40. Komuro T., Seki K., Horiguchi K. Ultrastructural characterization of the interstitial cells of Cajal. Arch Histol Cytol 1999, 62:295-316.
41. Faussone-Pellegrini M.S., Thuneberg L. Guide to the identification of interstitial cells of Cajal. Microsc Res Tech 1999, 47:248-266.
42. Wallace A.S., Burns A.J. Development of the enteric nervous system, smooth muscle and interstitial cells of Cajal in the human gastrointestinal tract. Cell Tissue Res 2005, 319:367-382.
43. Nicolescu M.I., Popescu L.M. Telocytes in the interstitium of human exocrine pancreas: ultrastructural evidence. Pancreas 2012, 41:949-956.
44. Bosco C., Díaz E., Gutiérrez R., González J., Perez J. Ganglionar nervous cells and telocytes in the pancreas of Octodon degus. Auton Neurosci 2013, 177:224-230.
45. Suciu L., Popescu L.M., Gherghiceanu M., et al. Telocytes in human term placenta: morphology and phenotype. Cells Tissues Organs 2010, 192:325-339.
46. Nicolescu M.I., Bucur A., Dinca O., Rusu M.C., Popescu L.M. Telocytes in parotid glands. Anat Rec (Hoboken) 2012, 295:378-385.
47. Kostin S. Myocardial telocytes: a specific new cellular entity. J Cell Mol Med 2010, 14:1917-1921.
48. Zhou J., Wang Y., Zhu P., et al. Distribution and characteristics of telocytes as nurse cells in the architectural organization of engineered heart tissues. Sci China Life Sci 2014, 57:241-247.
49. Graf R., Langer J.U., Schonfelder G., et al. The extravascular contractile system in the human placenta. Morphological and immunocytochemical investigations. Anat Embryol (Berl) 1994, 190:541-548.
50. Kohnen G., Kertschanska S., Demir R., Kaufmann P. Placental villous stroma as a model system for myofibroblast differentiation. Histochem Cell Biol 1996, 105:415-429.
51. Rosso P. Placental growth, development, and function in relation to maternal nutrition. Fed Proc 1980, 39:250-254.
52. Bosco C. Alcohol and xenobiotics in placenta damage. Comprehensive handbook of alcohol related pathology 2005, vol. 2:921-935. Elsevier Science Press, London.
53. Bosco C., Díaz E. Placental hypoxia and foetal development versus alcohol exposure in pregnancy. Alcohol Alcohol 2012, 47:109-117.
54. Bosco C. The cytotrophoblast: the first human amine precursor uptake and decarboxylation (APUD) cell. Med Sci Res 1995, 23:205-207.
55. Suciu L., Popescu L.M., Gherghiceanu M. Human placenta: de visu demonstration of interstitial Cajal-like cells. J Cell Mol Med 2007, 11:590-597.
56. Myatt L., Eis A.L., Brockman D.E., Kossenjans W., Greer I., Lyall F. Inducible (type II) nitric oxide synthase in human placental villous tissue of normotensive, pre eclamptic and intrauterine growth-restricted pregnancies. Placenta 1997, 18:261-268.
57. Kossenjans W., Eis A., Sahay R., Brockman D., Myatt L. Role of peroxinitrite in altered fetal placental vascular reactivity in diabetes or preeclampsia. Am J Physiol Heart Circ Physiol 2000, 278:H311-H319.
58. Martinez-Orgado J., Gonzalez R., Alonso M.J., Salaices M. Impairment of fetal endothelium-dependent relaxation in a rat model of preeclampsia by chronic nitric oxide synthase inhibition. J Soc Gynecol Investig 2004, 11:82-88.
59. Choi J.W., Im M.W., Pai S.H. Nitric oxide production increases during normal pregnancy and decreases in preeclampsia. Ann Clin Lab Sci 2002, 32:257-263.
60. Var A., Yildirim Y., Onur E., et al. Endothelial dysfunction in preeclampsia. Increased homocysteine and decreased nitric oxide levels. Gynecol Obstet Invest 2003, 56:221-224.
61. He Y., Smith K., Day A., Clark E., Licence R., Charnock-Jones S. Alternative splicing of vascular endothelial growth factor (VEGF) R1 (FLT-1) pre-m RNA is important for the regulation of VEGF activity. Mol Endocrinol 1999, 13:537-545.
62. Malamitsi-Puchner A., Boutsikou T., Economou E., et al. Vascular endothelial growth factor and placenta growth factor in intrauterine growth-restricted fetuses and neonatos. Mediators Inflamm 2005, 5:293-297.
63. Lyall F., Yong A., Boswell F., Kingdom J.C.P., Greer I.A. Placental expression of vascular endothelial growth factors in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery. Placenta 1997, 18:269-276.
64. Sgambati E., Marini M., Zappoli Thyrion G.D., et al. VEGF expression in the placenta from pregnancies complicated by hypertensive disorders. BJOG 2004, 111:564-570.
65. Oh M.J., Lee N.W., Shin J.H., et al. Vascular endothelial growth factor expression is unaltered in placentae and myometrial resistance arteries from pre-eclampsia patients. Acta Obstet Gynecol Scand 2006, 85:545-550.
66. Goldman C., Kendall R., Cabrera G., et al. Paracrine expression of native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate. Proc Natl Acad Sci USA 1998, 95:8795-8800.
67. Reynolds L., Redmer D. Angiogenesis in the placenta. Biol Reprod 2001, 64:1033-1040.
68. Cho G., Roh G., Kim H., et al. Differential expression of placenta growth factors and their receptors in the normal and pregnancy-induced hypertensive human placentas. J Korean Med Sci 2003, 18:402-408.
69. Zachary I. Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor. Am J Physiol Cell Physiol 2001, 280:1375-1386.
70. Bosco C., González J., Gutiérrez R., Parra-Cordero M., Barja P., Rodrigo R. Oxidative damage to pre-eclamptic placenta: immunohistochemical expression of VEGF, nitrotyrosine residues and von Willebrand factor. J Matern Fetal Neonatal Med 2012, 25:2339-2345.
71. Santos S., Peinado V.I., Ramirez J., et al. Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003, 167:1250-1256.
72. Farley A.E., Graham C.H., Smith G.N. Contractile properties of human placental anchoring villi. Am J Physiol Regul Integr Comp Physiol 2004, 287:R680-R685.
73. Ratts V.S., Tao X.J., Webster C.B., et al. Expression of BCL-2, BAX and BAK trophoblast layer of the term human placenta: a unique model of apoptosis within a syncytium. Placenta 2000, 21:361-366.
74. Mendilcioglu I., Karaveli S., Erdogan G., Simsek M., Taskin O., Ozekinci M. Apoptosis and expression of Bcl-2, Bax, p53, caspase-3, and Fas, Fas ligand in placentas complicated by preeclampsia. Clin Exp Obstet Gynecol 2001, 38:38-42.